Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in TARS — Tarsus Pharmaceuticals, Inc.

CIK 1390777 NEW YORK, NY
Back to TARS Full portfolio

Position in TARS

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$7,203,984
-$286,770 QoQ
Shares Held
114,458
+7.2% QoQ
Ownership
0.261%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 256 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 89% Shared 0% None 11%

Common Shares in TARS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. TARS ranks #79 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,672,623 $830,842,010
2 REGN
Regeneron Pharmaceuticals, Inc.
 758,492 $472,950,091
3 JAZZ
Jazz Pharmaceuticals plc
 1,578,013 $380,253,782
4 ALNY
Alnylam Pharmaceuticals, Inc.
 492,071 $148,128,128
5 INSM
INSMED Inc
 1,312,756 $139,966,036
6 MRNA
Moderna, Inc.
 1,701,675 $119,168,293
7 RVMD
Revolution Medicines, Inc.
 601,056 $112,565,759
8 INCY
Incyte Corp
 972,825 $110,279,435

All Filings in TARS

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,203,984 114,458
2026-03-31 $7,490,754 106,782
2025-12-31 $8,823,385 107,760
2025-09-30 $6,500,213 109,376
2025-06-30 $4,326,141 106,792
2025-03-31 $5,189,035 101,013
2024-12-31 $5,643,751 101,928
2024-09-30 $3,336,030 101,430
2024-06-30 $3,333,191 122,634
2024-03-31 $3,504,466 96,409
2023-12-31 $1,664,489 82,197
2023-09-30 $1,269,701 71,452
2023-06-30 $1,294,371 71,631
2023-03-31 $738,022 58,713
2022-12-31 $868,618 59,251
2022-09-30 $927,013 54,148
2022-06-30 $650,897 44,582
2022-03-31 $422,366 25,111
2021-12-31 $568,935 25,286
2021-09-30 $528,470 24,523
2021-06-30 $625,184 21,573
2021-03-31 $498,726 15,474
2020-12-31 $761,174 18,417